Cancer Program Annual Report - Eisenhower Medical Center

E I S E N H O W E R M E D I C A L C E N T E R
Observed Survival for Lung, Bronchus Cancer – Non-Small Cell Carcinoma
‘C340’, ‘C341’, ‘C342’, ‘C343’, ‘C348’, ‘C349’
Cases Diagnosed in 1998-2002
Data from 1 Program (Eisenhower Medical Center)
Cases Diagnosed in 1998-2002
Data from 1664 Programs (National)
Notice – When comparing survival rates between your cancer program and all other C0C-accredited cancer programs: if the
confidence intervals of stage-specific or overall survival rates overlap after five years, then there is no statistical difference
between survival rate of patients at your facility with that of other CoC-accredited cancer programs.
Figure 7
Figure 9
Data Table of Observed Survival for Lung,
Bronchus Cancer – Non-Small Cell Carcinoma
‘C340’, ‘C341’, ‘C342’, ‘C343’, ‘C348’, ‘C349’
Stage of ENTER 0.0 yr 1.0 yr 2.0 yr 3.0 yr 4.0 yr 5.0 yr 95%
Disease
Confidence
Stage I 91 100.0 75.8 63.7 56.0 50.5 42.9 32.8-53
Stage II 31 100.0 67.7 48.0 37.7 17.1 17.1 5.4-28.9
Stage III 95 100.0 38.9 20.0 9.5 7.4 4.2 0.7-7.7
Stage IV 149 100.0 22.1 9.4 5.4 3.4 3.4 0.9-5.9
Notice – When comparing survival rates between your cancer
program and all other C0C-accredited cancer programs: if the
confidence intervals of stage-specific or overall survival rates
overlap after five years, then there is no statistical difference
between survival rate of patients at your facility with that of
other CoC-accredited cancer programs.
Table 8
Stage of ENTER 0.0 yr 1.0 yr 2.0 yr 3.0 yr 4.0 yr 5.0 yr 95%
Disease
Confidence
Occult 307 100.0 42.3 26.1 18.6 14.5 11.9 8.2-15.6
Stage 0 841 100.0 49.6 33.2 24.9 20.3 17.4 14.8-20.1
Stage I 81228 100.0 79.2 65.1 55.5 48.6 43.2 42.9-43.6
Stage II 30332 100.0 64.9 44.5 34.4 27.9 23.6 23.1-24.1
Stage III 102852 100.0 43.9 22.7 14.7 10.8 8.5 8.4-8.7
Stage IV 141260 100.0 21.3 8.2 4.5 3.0 2.3 2.2-2.3
Notice – When comparing survival rates between your cancer
program and all other C0C-accredited cancer programs: if the
confidence intervals of stage-specific or overall survival rates
overlap after five years, then there is no statistical difference
between survival rate of patients at your facility with that of
other CoC-accredited cancer programs.
Table 10
15